Physician

James Kyle Russo, M.D.

According to 2025 Medicare claims, James Russo, M.D. (NPI: 1376700591) practices radiation oncology in the Lafayette, LA market, with the plurality of this provider's patient population coming from Lafayette, LA. This provider's primary affiliated billing organization is SOUTHERN UROLOGY, LLC (NPI: 1740441955; TIN: 262522952) and primary practice location at 70508-5739. Russo is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535) and Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Russo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 982 traditional Medicare patients, billed 22,639 HCPCS/CPT codes, and received $4,000,816 in Medicare payments. The top billing code was 74178 (Ct scan of abdomen and pelvis before and after contrast). Part D data shows 738 prescription claims across 258 beneficiaries totaling $9,959 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). 2023 DME data shows 12 claims. Open Payments data shows 31 records totaling $6,966. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,395,081 to $4,000,816. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,091 and ending at $9,959. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	318	7,841	$1,395,081
2016	371	8,460	$1,487,385
2017	616	13,398	$2,384,505
2018	305	4,563	$746,729
2019	95	1,632	$111,120
2020	652	20,531	$2,883,469
2021	853	21,113	$3,564,903
2022	953	22,205	$3,544,940
2023	1,025	21,719	$3,592,655
2024	982	22,639	$4,000,816

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	72	248	$7,091
2016	61	130	$3,462
2017	87	258	$6,505
2018	81	195	$4,049
2019	69	223	$3,881
2020	226	869	$335,769
2021	267	1,221	$1,215,553
2022	268	1,161	$906,070
2023	292	924	$328,058
2024	258	738	$9,959

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$143,843
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
74178	Ct scan of abdomen and pelvis before and after contrast	255	265	$165
77263	Complex radiation therapy planning	250	267	$121
77336	Continuing radiation therapy consultation per week	283	1,372	$61
77300	Calculation of radiation therapy dose	281	1,184	$47
36415	Insertion of needle into vein for collection of blood sample	244	331	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	398	18,936	$4,385
Alfuzosin Hcl Er	Alfuzosin Hcl	42	1,973	$593
Gabapentin	Gabapentin	35	1,050	$407
Venlafaxine Hcl Er	Venlafaxine Hcl	50	1,740	$354
Ondansetron Odt	Ondansetron	31	350	$269

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$6,966	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Kyle Russo, M.D.?

Tedicare shows public-source Medicare data for James Kyle Russo, M.D. (NPI 1376700591), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Kyle Russo, M.D. have ACO affiliation data?

James Kyle Russo, M.D. is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535) and Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to James Kyle Russo, M.D.?

James Kyle Russo, M.D. is linked to SOUTHERN UROLOGY, LLC (billing NPI 1740441955) in the available physician profile data.

Does James Kyle Russo, M.D. have Open Payments data?

James Kyle Russo, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.